SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CROCE, Carlo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.690
EU - Europa 3.546
AS - Asia 2.916
SA - Sud America 58
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 4
OC - Oceania 3
Totale 24.225
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.660
CN - Cina 1.441
UA - Ucraina 994
SG - Singapore 643
TR - Turchia 593
DE - Germania 561
IT - Italia 541
GB - Regno Unito 427
PL - Polonia 345
SE - Svezia 245
FI - Finlandia 231
VN - Vietnam 96
ID - Indonesia 73
FR - Francia 69
BR - Brasile 51
BE - Belgio 33
NL - Olanda 32
RU - Federazione Russa 27
CA - Canada 26
IR - Iran 17
KR - Corea 13
HK - Hong Kong 10
IN - India 9
AT - Austria 8
CZ - Repubblica Ceca 6
JP - Giappone 6
GR - Grecia 5
LT - Lituania 5
EU - Europa 4
RO - Romania 4
AU - Australia 3
IE - Irlanda 3
MY - Malesia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CH - Svizzera 2
CO - Colombia 2
ES - Italia 2
MX - Messico 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
SS - ???statistics.table.value.countryCode.SS??? 2
AM - Armenia 1
BD - Bangladesh 1
CL - Cile 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 24.225
Salva come PNG Salva come JPEG
Città #
Fairfield 2.681
Woodbridge 2.480
Houston 1.559
Ashburn 1.244
Jacksonville 1.139
Seattle 1.049
Chandler 991
Ann Arbor 892
Wilmington 877
Cambridge 857
Santa Clara 643
Singapore 483
Izmir 412
Warsaw 341
Nanjing 334
Princeton 251
San Diego 231
Beijing 215
Boardman 194
Ferrara 143
Addison 121
Milan 112
Dong Ket 96
Nanchang 94
Shanghai 93
Los Angeles 91
Shenyang 91
New York 81
Dearborn 76
Jakarta 72
Hebei 68
Mountain View 59
Tianjin 59
Jinan 56
Bremen 55
Jiaxing 53
Changsha 42
Falls Church 40
Kunming 40
London 40
Redwood City 39
Norwalk 35
San Mateo 35
Hangzhou 32
Zhengzhou 32
Brussels 31
Tappahannock 28
Guangzhou 27
Orange 27
Munich 26
Ningbo 26
Des Moines 25
Verona 24
Auburn Hills 23
Taizhou 22
Washington 21
Hefei 19
Philadelphia 18
Helsinki 15
Toronto 15
Indiana 14
Chicago 13
Lanzhou 13
Rome 12
Augusta 11
Changchun 11
Hong Kong 10
Frankfurt am Main 9
Hounslow 9
Redmond 9
Bologna 7
Kilburn 7
Monmouth Junction 7
Ottawa 7
Padova 7
Vienna 7
Amsterdam 6
Leawood 6
Naples 6
Ardabil 5
Berkeley 5
Napoli 5
Nuremberg 5
São Paulo 5
Tallahassee 5
Brno 4
Cagliari 4
Casalecchio Di Reno 4
Guiyang 4
Haikou 4
Palermo 4
Pavia 4
Prescot 4
Sant'Elpidio a Mare 4
Thessaloníki 4
Walnut 4
Wenzhou 4
Acton 3
Capo D'orlando 3
Chiswick 3
Totale 19.233
Salva come PNG Salva come JPEG
Nome #
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 234
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 181
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 175
Loss of miR-204 expression is a key event in melanoma 174
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 170
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 169
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 165
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 163
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 161
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 160
Identification of microRNA activity by Targets' Reverse EXpression. 157
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 156
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. 153
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 152
MicroRNA e cancro 152
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 151
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 150
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 149
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. 148
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. 148
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 148
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 147
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 146
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 143
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 143
MicroRNA involvement in hepatocellular carcinoma 142
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 142
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 141
null 139
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 137
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 137
Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. 136
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 135
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 135
MicroRNA expression profiling in human Barrett's carcinogenesis. 135
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 135
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 133
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 133
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 133
null 132
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC 132
Knockout mice reveal a tumor suppressor function for Testin 131
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 130
MicroRNA genes are frequently located near mouse cancer susceptibility loci 128
null 128
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 128
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 128
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 128
null 128
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 127
null 127
Tumor suppressor functions of ARLTS1 in lung cancers 127
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- α stimulation and their possible roles in regulating the response to endotoxin shock 127
A microRNA DNA methylation signature for human cancer metastasis 126
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 126
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 126
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. 124
Reprogramming of miRNA networks in cancer and leukemia 123
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. 122
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. 122
null 122
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias 120
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function 120
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 119
null 119
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer 119
Extensive modulation of a set of microRNAs in primary glioblastoma 118
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 118
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 117
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 117
MicroRNA deregulation in human thyroid papillary carcinomas 117
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention 116
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 116
null 116
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 115
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 115
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 115
MicroRNAs 221 and 222 bypass quiescence and compromise cell survival 114
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 113
The role of microRNA genes in papillary thyroid carcinoma 113
A microRNA signature of hypoxia 113
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 113
null 111
TCL1 promotes blastomere proliferation through nuclear transfer, but not direct phosphorylation, of AKT/PKB in early mouse embryos 111
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 111
null 111
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers 111
Oncogenic role of miR-483-3p at the IGF2/483 locus 111
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 111
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 111
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 111
Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis 110
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 110
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 110
Mammalian microRNAs: a small world for fine-tuning gene expression 110
microRNA involvement in hepatocellular carcinoma 108
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism 108
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 108
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 108
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 107
Totale 13.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 896
Totale 109.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.540 0 0 0 0 0 0 547 611 527 519 197 139
2020/20213.520 274 369 191 408 211 340 155 389 98 406 401 278
2021/20222.731 124 318 263 67 95 108 151 135 80 201 287 902
2022/20232.423 249 98 61 306 380 391 103 259 323 19 131 103
2023/20241.074 126 169 60 38 79 182 32 69 23 18 30 248
2024/20251.726 144 94 387 137 585 360 19 0 0 0 0 0
Totale 24.543